RhoGDI2 as a therapeutic target in cancer

Bibliography

• Steeg PS. Metastasis: a therapeutic target for cancer. Nat Clin Prac Oncol 2008;5(4):206-19
   PubMedGoogle Scholar
• Nobes CD, Hall A. Rho, Rac and Cdc42 GTPases: regulators of actin structures, cell adhesion and motility. Biochem Soc Trans 1995;23(3):456-9
   PubMed Web of Science ®Google Scholar
• Aznar S, Lacal JC. Rho signals to cell growth and apoptosis. Cancer Lett 2001;165(1):1-10
   PubMed Web of Science ®Google Scholar
• Vega FM, Ridley AJ. RhoGTPases in cancer cell biology. FEBS Lett 2008;582(14):2093-101
   PubMed Web of Science ®Google Scholar
• Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature 2002;420(6916):629-35
   PubMed Web of Science ®Google Scholar
• Gomez del Pulgar T, Benitah SA, Valeron PF, Rho GTPase expression in tumourigenesis: evidence for a significant link. Bioessays 2005;27(6):602-13
   PubMed Web of Science ®Google Scholar
• Bishop AL, Hall A. RhoGTPases and their effector proteins. Biochem J 2000;348(Pt 2):241-55
   PubMedGoogle Scholar
• Schmidt A, Hall A. Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. Genes Dev 2002;16(13):1587-609
   PubMed Web of Science ®Google Scholar
• Moon SY, Zheng Y. Rho GTPase-activation proteins in cell regulation. Trends Cell Biol 2003;13(1):13-22
   PubMed Web of Science ®Google Scholar
• Ueda T, Kikuchi A, Ohga N, Purification and characterization from bovine brain cytosol of a novel regulatory protein inhibiting the dissociation of GDP from and the subsequent binding of GTP to rhoB p20; a ras p21-like GTP-binding protein. J Biol Chem 1990;265(16):9373-80
   PubMed Web of Science ®Google Scholar
• Fukumoto Y, Kaibuchi K, Hori Y, Molecular cloning and characterization of novel type of regulatory protein (GDI) for the Rho proteins, ras p21-like small GTP-binding proteins. Oncogene 1990;5(9):1321-8
   PubMed Web of Science ®Google Scholar
• Dovas A, Couchman JR. RhoGDI: multiple functions in the regulation of Rho family GTPase activities. Biochem J 2005;390(Pt1):1-9
   PubMedGoogle Scholar
• Olofsson B. Rho guanine dissociation inhibitors: pivotal molecules in cellular signalling. Cell Signal 1999;11(8):545-54
   PubMed Web of Science ®Google Scholar
• Leonard D, Hart M, Platko J, The identification and characterization of a GDP-dissociation inhibitor (GDI) for the Cdc42Hs proteins. J Biol Chem 1992;267(32):22860-8
   PubMed Web of Science ®Google Scholar
• Zalcman G, Closson V, Camonis J, RhoGDI-3 is a new GDP dissociation inhibitor (GDI). Identification of a non-cytosolic GDI protein interacting with the small GTP-binding proteins RhoB and RhoG. J Biol Chem 1996;271(48):30366-74
   PubMed Web of Science ®Google Scholar
• Adra CN, Manor D, Ko JL, RhoGDIgamma: a GDP-dissociation inhibitor for Rho proteins with preferential expression in brain and pancreas. Proc Natl Acad Sci 1997;94(9):4279-84
   PubMed Web of Science ®Google Scholar
• Lelias JM, Adra CN, Wulf GM, cDNA cloning of a human mRNA preferentially expressed in hematopoietic cells and with homology to a GDP-dissociation inhibitor for the Rho GTP-binding proteins. Proc Natl Acad Sci 1993;90(4):1479-83
   PubMed Web of Science ®Google Scholar
• Scherle P, Behrens T, Staudt LM. Ly-GDI, a GDP-dissociation inhibitor of the RhoA GTP-binding protein, is expressed preferentially in lymphocytes. Proc Natl Acad Sci 1993;90(16):7568-72
   PubMed Web of Science ®Google Scholar
• DerMardirossian C, Bokoch GM. GDIs: central regulatory molecules in Rho GTPase activation. Trends Cell Biol 2005;15(7):356-63
   PubMed Web of Science ®Google Scholar
• Dovas A, Couchman JR. RhoGDI: multiple functions in the regulation of Rho family GTPase activities. Biochem J 2005;390(Pt 1):1-9
   PubMedGoogle Scholar
• Dransart E, Olofsson B, Cherfils J. RhoGDIs revisited: novel roles in Rho regulation. Traffic 2005;6(11):957-66
   PubMed Web of Science ®Google Scholar
• Zhang B. Rho GDP dissociation inhibitors as potential targets for anticancer treatment. Drug Resist Updat 2006;9(3):134-41
   PubMed Web of Science ®Google Scholar
• Golovanov AP, Chuang TH, DerMardirossian C, Structure–activity relationships in flexible protein domains: regulation of rho GTPases by RhoGDI and D4 GDI. J Mol Biol 2001;305(1):121-35
   PubMed Web of Science ®Google Scholar
• Longenecker K, Read P, Derewenda U, How RhoGDI binds Rho. Acta Crystallogr D Biol Crystallogr 1999;55(Pt 9):1503-15
   PubMedGoogle Scholar
• Grizot S, Fauré J, Fieschi F, Crystal structure of the Rac1–RhoGDI complex involved in NADPH oxidase activation. Biochemistry 2001;40(34):10007-13
   PubMed Web of Science ®Google Scholar
• Hoffman GR, Nassar N, Cerione RA. Structure of the Rho family GTP-binding protein Cdc42 in complex with the multifunctional regulator RhoGDI. Cell 2000;100(3):345-56
   PubMed Web of Science ®Google Scholar
• Scheffzek K, Stephan I, Jensen ON, The Rac–RhoGDI complex and the structural basis for the regulation of Rho proteins by RhoGDI. Nat Struct Biol 2000;7(2):122-6
   PubMedGoogle Scholar
• Vetter IR, Wittinghofer A. The guanine nucleotide-binding switch in three dimensions. Science 2001;294(5545):1299-304
   PubMed Web of Science ®Google Scholar
• Keep NH, Barnes M, Barsukov I, A modulator of rho family G proteins, rhoGDI, binds these G proteins via an immunoglobulin-like domain and a flexible N-terminal arm. Structure 1997;5(5):623-33
   PubMed Web of Science ®Google Scholar
• Gosser YQ, Nomanbhoy TK, Aghazadeh B, C-terminal binding domain of Rho GDP-dissociation inhibitor directs N-terminal inhibitory peptide to GTPases. Nature 1997;387(6635):814-9
   PubMed Web of Science ®Google Scholar
• Robbe K, Otto-Bruc A, Chardin P, Dissociation of GDP dissociation inhibitor and membrane translocation are required for efficient activation of Rac by the Dbl homology-pleckstrin homology region of Tiam. J Biol Chem 2003;278(7):4756-62
   PubMed Web of Science ®Google Scholar
• Mehta D, Rahman A, Malik AB. Protein kinase C-alpha signals Rho-guanine nucleotide dissociation inhibitor phosphorylation and rho activation and regulates the endothelial cell barrier function. J Biol Chem 2001;276(25):22614-20
   PubMed Web of Science ®Google Scholar
• DerMardirossian C, Schnelzer A, Bokoch GM. Phosphorylation of RhoGDI by Pak1 mediates dissociation of Rac GTPase. Mol Cell 2004;15(1):117-27
   PubMed Web of Science ®Google Scholar
• DerMardirossian C, Rocklin G, Seo JY, Phosphorylation of RhoGDI by Src regulates Rho GTPase binding and cytosol-membrane cycling. Mol Biol Cell 2006;17(11):4760-8
   PubMed Web of Science ®Google Scholar
• Takahashi K, Sasaki T, Mammoto A, Direct interaction of the Rho GDP dissociation inhibitor with ezrin/radixin/moesin initiates the activation of the Rho small G protein. J Biol Chem 1997;272(37):23371-5
   PubMed Web of Science ®Google Scholar
• Kim O, Yang J, Qiu Y. Selective activation of small GTPase RhoA by tyrosine kinase Etk through its pleckstrin homology domain. J Biol Chem 2002;277(33):30066-71
   PubMed Web of Science ®Google Scholar
• Yamashita T, Tohyama M. The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI. Nat Neurosci 2003;6(5):461-7
   PubMed Web of Science ®Google Scholar
• Chuang TH, Bohl BP, Bokoch GM. Biologically active lipids are regulators of Rac.GDI complexation. J Biol Chem 1993;268(35):26206-11
   PubMed Web of Science ®Google Scholar
• Fauré J, Vignais PV, Dagher MC. Phosphoinositide-dependent activation of Rho A involves partial opening of the RhoA/Rho-GDI complex. Eur J Biochem 1999;262(3):879-89
   PubMedGoogle Scholar
• Yonemura S, Matsui T, Tsukita S, Rho-dependent and -independent activation mechanisms of ezrin/radixin/moesin proteins: an essential role for polyphosphoinositides in vivo. J Cell Sci 2002;115(Pt 12):2569-80
   PubMed Web of Science ®Google Scholar
• Fievet BT, Gautreau A, Roy C, Phosphoinositide binding and phosphorylation act sequentially in the activation mechanism of ezrin. J Cell Biol 2004;164(5):653-9
   PubMed Web of Science ®Google Scholar
• Abramovici H, Mojtabaie P, Parks RJ, Diacylglycerol kinase ζ regulates actin cytoskeleton reorganization through dissociation of Rac1 from RhoGDI. Mol Biol Cell 2009;20(7):2049-59
   PubMed Web of Science ®Google Scholar
• Ma L, Xu G, Sotnikova A, Loss of expression of LyGDI (ARHGDIB), a rho GDP-dissociation inhibitor, in Hodgkin lymphoma. Br J Haematol 2007;139(2):217-23
   PubMed Web of Science ®Google Scholar
• Seraj MJ, Harding MA, Gildea JJ, The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines. Clin Exp Metastasis 2000;18(6):519-25
   PubMed Web of Science ®Google Scholar
• Gildea JJ, Seraj MJ, Oxford G, RhoGDI2 is an invasion and metastasis suppressor gene in human cancer. Cancer Res 2002;62(22):6418-23
   PubMed Web of Science ®Google Scholar
• Theodorescu D, Sapinoso LM, Conaway MR, Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer. Clin Cancer Res 2004;10(11):3800-6
   PubMed Web of Science ®Google Scholar
• Titus B, Frierson HF Jr, Conaway M, Endothelin axis is a target of the lung metastasis suppressor gene RhoGDI2. Cancer Res 2005;65(16):7320-7
   PubMed Web of Science ®Google Scholar
• Wu Y, McRoberts K, Berr SS, Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia. Oncogene 2007;26(5):765-73
   PubMed Web of Science ®Google Scholar
• Tapper J, Kettunen E, El-Rifai W, Changes in gene expression during progression of ovarian carcinoma. Cancer Genet Cytogenet 2001;128(1):1-6
   PubMedGoogle Scholar
• Zhang Y, Zhang B. D4-GDI, a Rho GTPase regulator, promotes breast cancer cell invasiveness. Cancer Res 2006;66(11):5592-8
   PubMed Web of Science ®Google Scholar
• Zhang Y, Rivera Rosado LA, Moon SY, Silencing of D4-GDI inhibits growth and invasive behavior in MDA-MB-231 cells by activation of Rac-dependent p38 and JNK signaling. J Biol Chem 2009;284(19):12956-65
   PubMed Web of Science ®Google Scholar
• Schunke D, Span P, Ronneburg H, Cyclooxygenase-2 is a target gene of rho GDP dissociation inhibitor beta in breast cancer cells. Cancer Res 2007;67(22):10694-702
   PubMed Web of Science ®Google Scholar
• Dittmer J. The biology of the Ets1 proto-oncogene. Mol Cancer 2003;2:29: published online 20 August 2003, doi:10.1186/1476-4598-2-29
   PubMedGoogle Scholar
• Seth A, Watson DK. ETS transcription factors and their emerging roles in human cancer. Eur J Cancer 2005;41(16):2462-78
   PubMed Web of Science ®Google Scholar
• Hood JD, Cheresh DA. Role of integrins in cell invasion and migration. Nat Rev Cancer 2002;2(2):91-100
   PubMed Web of Science ®Google Scholar
• Larkins TL, Nowell M, Singh S, Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression. BMC Cancer 2006;6:181: published online 10 July 2006, doi:10.1186/1471-2407-6-181
   PubMed Web of Science ®Google Scholar
• Jiang WG, Watkins G, Lane J, Prognostic value of Rho GTPases and Rho guanine nucleotide dissociation inhibitors in human breast cancers. Clin Cancer Res 2003;9(17):6432-40
   PubMed Web of Science ®Google Scholar
• Hu LD, Zou HF, Zhan SX, Biphasic expression of RhoGDI2 in the progression of breast cancer and its negative relation with lymph node metastasis. Oncol Rep 2007;17(6):1383-9
   PubMed Web of Science ®Google Scholar
• Cho HJ, Baek KE, Park SM, RhoGDI2 expression is associated with tumor growth and malignant progression of gastric cancer. Clin Cancer Res 2009;15(8):2612-9
   PubMed Web of Science ®Google Scholar
• Adra CN, Ko J, Leonard D, Identification of a novel protein with GDP dissociation inhibitor activity for the ras-like proteins CDC42Hs and Rac 1. Genes Chromosomes Cancer 1993;8(4):253-61
   PubMed Web of Science ®Google Scholar
• Gorvel JP, Chang TC, Boretto J, Differential properties of D4/LyGDI versus RhoGDI: phosphorylation and rho GTPase selectivity. FEBS Lett 1998;422(2):269-73
   PubMed Web of Science ®Google Scholar
• Moissoglu K, McRoberts KS, Meier JA, Rho GDP dissociation inhibitor 2 suppresses metastasis via unconventional regulation of RhoGTPases. Cancer Res 2009;69(7):2838-44
   PubMed Web of Science ®Google Scholar
• Wu Y, Moissoglu K, Wang H, Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function. Proc Natl Acad Sci 2009;106(14):5807-12
   PubMed Web of Science ®Google Scholar
• Huang CY, Yang LC, Liu KY, ZAK negatively regulates RhoGDIbeta-induced Rac1-mediated hypertrophic growth and cell migration. J Biomed Sci 2009;16:56: published online 18 June 2009, doi:10.1186/1423-0127-16-56
   PubMed Web of Science ®Google Scholar
• Huang CY, Yang LC, Liu KY, RhoGDIbeta-induced hypertrophic growth in H9c2 cells is negatively regulated by ZAK. J Biomed Sci 2009;16:11: published online 22 January 2009, doi:10.1186/1423-0127-16-11
   PubMed Web of Science ®Google Scholar
• Liu TC, Huang CJ, Chu YC, Cloning and expression of ZAK, a mixed lineage kinase-like protein containing a leucine-zipper and a sterile-alpha motif. Biochem Biophys Res Commun 2000;274(3):811-6
   PubMed Web of Science ®Google Scholar
• Sun D, Xu D, Zhang B. Rac signaling in tumorigenesis and as target for anticancer drug development. Drug Resist Updat 2006;9(6):274-87
   PubMed Web of Science ®Google Scholar
• Groysman M, Hornstein I, Alcover A, Vav1 and Ly-GDI two regulators of Rho GTPases, function cooperatively as signal transducers in T cell antigen receptor-induced pathways. J Biol Chem 2002;277(51):50121-30
   PubMed Web of Science ®Google Scholar
• Hancock JF, Hall A. A novel role for RhoGDI as an inhibitor of GAP proteins. EMBO J 1993;12(5):1915-21
   PubMed Web of Science ®Google Scholar
• Kweon SM, Cho YJ, Minoo P, Activity of the Bcr GTPase-activating domain is regulated through direct protein/protein interaction with the Rho guanine nucleotide dissociation inhibitor. J Biol Chem 2008;283(6):3023-30
   PubMed Web of Science ®Google Scholar
• Pommier Y, Cherfils J. Interfacial inhibition of macromolecular interactions: nature's paradigm for drug discovery. Trends Pharmacol Sci 2005;26(3):138-45
   PubMed Web of Science ®Google Scholar
• Zeghouf M, Guibert B, Zeeh JC, Arf, Sec7 and Brefeldin A: a model towards the therapeutic inhibition of guanine nucleotide-exchange factors. Biochem Soc Trans 2005;33(Pt 6):1265-8
   PubMedGoogle Scholar
• Fire A, Xu S, Montgomery MK, Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998;391(6669):806-11
   PubMed Web of Science ®Google Scholar
• Zimmermann TS, Lee AC, Akinc A, RNAi-mediated gene silencing in non-human primates. Nature 2006;441(7089):111-4
   PubMed Web of Science ®Google Scholar
• Fritz G, Kaina B. Rho GTPases: promising cellular targets for novel anticancer drugs. Curr Cancer Drug Targets 2006;6(1):1-14
   PubMed Web of Science ®Google Scholar
• Walker K, Olson MF. Targeting Ras and Rho GTPases as opportunities for cancer therapeutics. Curr Opin Genet Dev 2005;15(1):62-8
   PubMed Web of Science ®Google Scholar
• Gao Y, Dickerson JB, Guo F, Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc Natl Acad Sci 2004;101(20):7618-23
   PubMed Web of Science ®Google Scholar
• Guillemot JC, Kruskal BA, Adra CN, Targeted disruption of guanosine diphosphate-dissociation inhibitor for Rho-related proteins, GDID4: normal hematopoietic differentiation but subtle defect in superoxide production by macrophages derived from in vitro embryonal stem cell differentiation. Blood 1996;88(7):2722-31
   PubMed Web of Science ®Google Scholar
• Yin L, Schwartzberg P, Scharton-Kersten TM, Immune responses in mice deficient in Ly-GDI, a lymphoid-specific regulator of Rho GTPases. Mol Immunol 1997;34(6):481-91
   PubMed Web of Science ®Google Scholar